PROJECT GOLD Trademark

Trademark Overview


On Friday, September 1, 2023, a trademark application was filed for PROJECT GOLD with the United States Patent and Trademark Office. The USPTO has given the PROJECT GOLD trademark a serial number of 98160589. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, September 10, 2024. This trademark is owned by Angels for Change Inc.. The PROJECT GOLD trademark is filed in the Treatment & Processing of Materials Services, Advertising, Business and Retail Services, Medical & Beauty Services & Agricultural Services, Personal, and Legal & Social Services categories with the following description:

Consulting services in the field of pharmaceutical manufacturing, namely, generic drugs for cancer treatment

Promoting the interests of cancer patients by means of public advocacy, specifically access and availability of generic drugs for cancer treatment; Promoting public awareness of supply chain issues of generic cancer treatment drugs by means of public advocacy; Pharmaceutical cost management services and drug utilization review services, namely, generic drugs for cancer treatment; Providing advertising, marketing and promotional services for the pharmaceutical and medical industry, namely, the manufacture and distribution of generic cancer treatment drugs; Promoting public interest and awareness of availability and accessibility of generic drugs for cancer treatment; Consulting in the field of distributorship services for pharmaceuticals, namely, generic drugs for cancer treatment

Providing patient advocate services in the field of cancer treatment, namely, increasing access to and availability of generic drugs therefor; Providing patient advocate and case management services, namely, coordinating the procurement and administration of medication, specifically for generic drugs for cancer treatment; Providing information about legal eligibility requirements for government medical and pharmaceutical programs, namely, for access to and availability of generic drugs for cancer treatment

Pharmaceutical advice, namely, to facilitate and subsidize access to and availability of generic drugs for cancer treatment; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals, namely, generic drugs for cancer treatment
project gold

General Information


Serial Number98160589
Word MarkPROJECT GOLD
Filing DateFriday, September 1, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, September 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 10, 2024

Trademark Statements


Goods and ServicesConsulting services in the field of pharmaceutical manufacturing, namely, generic drugs for cancer treatment
Goods and ServicesPromoting the interests of cancer patients by means of public advocacy, specifically access and availability of generic drugs for cancer treatment; Promoting public awareness of supply chain issues of generic cancer treatment drugs by means of public advocacy; Pharmaceutical cost management services and drug utilization review services, namely, generic drugs for cancer treatment; Providing advertising, marketing and promotional services for the pharmaceutical and medical industry, namely, the manufacture and distribution of generic cancer treatment drugs; Promoting public interest and awareness of availability and accessibility of generic drugs for cancer treatment; Consulting in the field of distributorship services for pharmaceuticals, namely, generic drugs for cancer treatment
Goods and ServicesProviding patient advocate services in the field of cancer treatment, namely, increasing access to and availability of generic drugs therefor; Providing patient advocate and case management services, namely, coordinating the procurement and administration of medication, specifically for generic drugs for cancer treatment; Providing information about legal eligibility requirements for government medical and pharmaceutical programs, namely, for access to and availability of generic drugs for cancer treatment
Goods and ServicesPharmaceutical advice, namely, to facilitate and subsidize access to and availability of generic drugs for cancer treatment; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals, namely, generic drugs for cancer treatment

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateWednesday, September 27, 2023
Primary Code040
First Use Anywhere DateFriday, June 30, 2023
First Use In Commerce DateFriday, June 30, 2023

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, September 27, 2023
Primary Code035
First Use Anywhere DateFriday, June 30, 2023
First Use In Commerce DateFriday, June 30, 2023

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 27, 2023
Primary Code044
First Use Anywhere DateFriday, June 30, 2023
First Use In Commerce DateFriday, June 30, 2023

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 27, 2023
Primary Code045
First Use Anywhere DateFriday, June 30, 2023
First Use In Commerce DateFriday, June 30, 2023

Trademark Owner History


Party NameCurae Pharma360, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94105

Party NameAngels for Change Inc.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressValrico, FL 33594

Party NameCurae Pharma360, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94105

Party NameAngels for Change Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressValrico, FL 33594

Trademark Events


Event DateEvent Description
Wednesday, February 7, 2024USE AMENDMENT FILED
Tuesday, September 5, 2023NEW APPLICATION ENTERED
Wednesday, September 27, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 6, 2024TEAS AMENDMENT OF USE RECEIVED
Wednesday, February 7, 2024AMENDMENT TO USE PROCESSING COMPLETE
Friday, May 3, 2024NON-FINAL ACTION E-MAILED
Friday, May 3, 2024USE AMENDMENT ACCEPTED
Tuesday, April 30, 2024ASSIGNED TO EXAMINER
Friday, May 3, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 3, 2024NON-FINAL ACTION WRITTEN
Monday, August 5, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 5, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 6, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, August 6, 2024EXAMINERS AMENDMENT E-MAILED
Tuesday, August 6, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, August 6, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 6, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, May 4, 2024NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Monday, August 5, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 10, 2024PUBLISHED FOR OPPOSITION
Tuesday, September 10, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED